Nan Huang, Zhixuan Bian, Chang Xu, Yue Zhang, Li Liu, Zhongqi Cui, Shasha Zhao, Qiangyuan Fan, Shaobo Xue, Yan Chen, Qiuhui Pan, Fenyong Sun
{"title":"WTAP在肝细胞癌中通过m6a - foxm1依赖的方式参与DNA损伤应答。","authors":"Nan Huang, Zhixuan Bian, Chang Xu, Yue Zhang, Li Liu, Zhongqi Cui, Shasha Zhao, Qiangyuan Fan, Shaobo Xue, Yan Chen, Qiuhui Pan, Fenyong Sun","doi":"10.1038/s41420-025-02639-x","DOIUrl":null,"url":null,"abstract":"<p><p>N6-Methyladenosine (m<sup>6</sup>A) is one of the most abundant RNA modifications that occur in eukaryotes. The relationship between m<sup>6</sup>A methylation and DNA damage repair (DDR) is still unclear. As an important chaperone protein of m<sup>6</sup>A methyltransferase, the role of Wilm's tumor-associated protein (WTAP) in DDR has not been studied in detail. We identified that WTAP was markedly upregulated in HCC cells with DNA damage induction. Further investigations revealed that WTAP was engaged in DDR and WTAP knockdown resulted in a significant decrease of the stability of the DDR-related transcription factor Forkhead Box M1 (FOXM1) mRNA, eventually preventing DDR. WTAP deficiency inhibited cell growth both in vivo and in vitro. Moreover, WTAP silencing sensitized HCC cells to cisplatin, a well-known DNA damage agent. Altogether, our findings demonstrate that WTAP is the dominant m<sup>6</sup>A -related modulator upon DNA damage and functions by stabilizing FOXM1. In addition, WTAP deficiency saliently sensitized HCC cells to cisplatin both in vitro and in vivo.</p>","PeriodicalId":9735,"journal":{"name":"Cell Death Discovery","volume":"11 1","pages":"397"},"PeriodicalIF":7.0000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12373989/pdf/","citationCount":"0","resultStr":"{\"title\":\"WTAP participates in the DNA damage response via an m<sup>6</sup>A-FOXM1-dependent manner in hepatocellular carcinoma.\",\"authors\":\"Nan Huang, Zhixuan Bian, Chang Xu, Yue Zhang, Li Liu, Zhongqi Cui, Shasha Zhao, Qiangyuan Fan, Shaobo Xue, Yan Chen, Qiuhui Pan, Fenyong Sun\",\"doi\":\"10.1038/s41420-025-02639-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>N6-Methyladenosine (m<sup>6</sup>A) is one of the most abundant RNA modifications that occur in eukaryotes. The relationship between m<sup>6</sup>A methylation and DNA damage repair (DDR) is still unclear. As an important chaperone protein of m<sup>6</sup>A methyltransferase, the role of Wilm's tumor-associated protein (WTAP) in DDR has not been studied in detail. We identified that WTAP was markedly upregulated in HCC cells with DNA damage induction. Further investigations revealed that WTAP was engaged in DDR and WTAP knockdown resulted in a significant decrease of the stability of the DDR-related transcription factor Forkhead Box M1 (FOXM1) mRNA, eventually preventing DDR. WTAP deficiency inhibited cell growth both in vivo and in vitro. Moreover, WTAP silencing sensitized HCC cells to cisplatin, a well-known DNA damage agent. Altogether, our findings demonstrate that WTAP is the dominant m<sup>6</sup>A -related modulator upon DNA damage and functions by stabilizing FOXM1. In addition, WTAP deficiency saliently sensitized HCC cells to cisplatin both in vitro and in vivo.</p>\",\"PeriodicalId\":9735,\"journal\":{\"name\":\"Cell Death Discovery\",\"volume\":\"11 1\",\"pages\":\"397\"},\"PeriodicalIF\":7.0000,\"publicationDate\":\"2025-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12373989/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell Death Discovery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41420-025-02639-x\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Death Discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41420-025-02639-x","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
n6 -甲基腺苷(m6A)是真核生物中最丰富的RNA修饰之一。m6A甲基化与DNA损伤修复(DDR)之间的关系尚不清楚。作为m6A甲基转移酶的重要伴侣蛋白,Wilm's tumor-associated protein (WTAP)在DDR中的作用尚未得到详细研究。我们发现WTAP在DNA损伤诱导的HCC细胞中显著上调。进一步研究发现WTAP参与DDR, WTAP敲低导致DDR相关转录因子叉头盒M1 (FOXM1) mRNA稳定性显著降低,最终阻止DDR发生。WTAP缺乏抑制了细胞在体内和体外的生长。此外,WTAP沉默使HCC细胞对顺铂敏感,顺铂是一种众所周知的DNA损伤剂。总之,我们的研究结果表明,WTAP是m6A相关的主要调节剂,通过稳定FOXM1来调节DNA损伤和功能。此外,WTAP缺乏在体外和体内均显著使HCC细胞对顺铂敏感。
WTAP participates in the DNA damage response via an m6A-FOXM1-dependent manner in hepatocellular carcinoma.
N6-Methyladenosine (m6A) is one of the most abundant RNA modifications that occur in eukaryotes. The relationship between m6A methylation and DNA damage repair (DDR) is still unclear. As an important chaperone protein of m6A methyltransferase, the role of Wilm's tumor-associated protein (WTAP) in DDR has not been studied in detail. We identified that WTAP was markedly upregulated in HCC cells with DNA damage induction. Further investigations revealed that WTAP was engaged in DDR and WTAP knockdown resulted in a significant decrease of the stability of the DDR-related transcription factor Forkhead Box M1 (FOXM1) mRNA, eventually preventing DDR. WTAP deficiency inhibited cell growth both in vivo and in vitro. Moreover, WTAP silencing sensitized HCC cells to cisplatin, a well-known DNA damage agent. Altogether, our findings demonstrate that WTAP is the dominant m6A -related modulator upon DNA damage and functions by stabilizing FOXM1. In addition, WTAP deficiency saliently sensitized HCC cells to cisplatin both in vitro and in vivo.
期刊介绍:
Cell Death Discovery is a multidisciplinary, international, online-only, open access journal, dedicated to publishing research at the intersection of medicine with biochemistry, pharmacology, immunology, cell biology and cell death, provided it is scientifically sound. The unrestricted access to research findings in Cell Death Discovery will foster a dynamic and highly productive dialogue between basic scientists and clinicians, as well as researchers in industry with a focus on cancer, neurobiology and inflammation research. As an official journal of the Cell Death Differentiation Association (ADMC), Cell Death Discovery will build upon the success of Cell Death & Differentiation and Cell Death & Disease in publishing important peer-reviewed original research, timely reviews and editorial commentary.
Cell Death Discovery is committed to increasing the reproducibility of research. To this end, in conjunction with its sister journals Cell Death & Differentiation and Cell Death & Disease, Cell Death Discovery provides a unique forum for scientists as well as clinicians and members of the pharmaceutical and biotechnical industry. It is committed to the rapid publication of high quality original papers that relate to these subjects, together with topical, usually solicited, reviews, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.